Pages that link to "Q34807142"
Jump to navigation
Jump to search
The following pages link to Elevated cerebrospinal fluid BACE1 activity in incipient Alzheimer disease (Q34807142):
Displaying 50 items.
- Biological markers of amyloid beta-related mechanisms in Alzheimer's disease (Q24622136) (← links)
- Amyloid-beta Alzheimer targets - protein processing, lipid rafts, and amyloid-beta pores (Q26738355) (← links)
- Insight into the Molecular Imaging of Alzheimer's Disease (Q26768635) (← links)
- Fluid Biomarkers in Clinical Trials of Alzheimer's Disease Therapeutics (Q26784569) (← links)
- Body fluid biomarkers in Alzheimer's disease (Q26830098) (← links)
- New pharmacological strategies for treatment of Alzheimer's disease: focus on disease modifying drugs (Q26866006) (← links)
- BACE1 inhibition induces a specific cerebrospinal fluid β-amyloid pattern that identifies drug effects in the central nervous system (Q28480522) (← links)
- Increased CSF levels of phosphorylated neurofilament heavy protein following bout in amateur boxers (Q28535187) (← links)
- Amyloid and tau cerebrospinal fluid biomarkers in HIV infection (Q33520347) (← links)
- Neuroinflammation in Lyme neuroborreliosis affects amyloid metabolism (Q33612995) (← links)
- Cerebrospinal fluid BACE1 activity and markers of amyloid precursor protein metabolism and axonal degeneration in Alzheimer's disease (Q33686357) (← links)
- CNS amyloid-β, soluble APP-α and -β kinetics during BACE inhibition. (Q33735544) (← links)
- Cerebrospinal fluid biomarkers in mild cognitive impairment and dementia (Q33936708) (← links)
- Cerebrospinal fluid and plasma biomarkers in Alzheimer disease (Q34098866) (← links)
- BACE1 gene variants do not influence BACE1 activity, levels of APP or Aβ isoforms in CSF in Alzheimer's disease (Q34174700) (← links)
- β-Secretase-1 elevation in aged monkey and Alzheimer's disease human cerebral cortex occurs around the vasculature in partnership with multisystem axon terminal pathogenesis and β-amyloid accumulation (Q34268487) (← links)
- A common BACE1 polymorphism is a risk factor for sporadic Creutzfeldt-Jakob disease (Q34405864) (← links)
- An overview of biomarkers in Alzheimer′s disease (Q34574944) (← links)
- Amyloid precursor protein (APP) processing genes and cerebrospinal fluid APP cleavage product levels in Alzheimer's disease (Q34728911) (← links)
- Cerebrospinal fluid (CSF) neuronal biomarkers across the spectrum of HIV infection: hierarchy of injury and detection (Q34776835) (← links)
- Cerebrospinal Aβ11-x and 17-x levels as indicators of mild cognitive impairment and patients' stratification in Alzheimer's disease. (Q34824216) (← links)
- Heteromers of amyloid precursor protein in cerebrospinal fluid (Q34981218) (← links)
- Cerebrospinal fluid biomarkers of white matter lesions - cross-sectional results from the LADIS study (Q35008855) (← links)
- Cerebrospinal fluid biomarker and brain biopsy findings in idiopathic normal pressure hydrocephalus (Q35123209) (← links)
- The "Alzheimer's disease signature": potential perspectives for novel biomarkers. (Q35339326) (← links)
- Cognitive performance and cerebrospinal fluid biomarkers of neurodegeneration: a study of patients with bipolar disorder and healthy controls (Q35587114) (← links)
- Cerebrospinal Fluid P-Tau181P: Biomarker for Improved Differential Dementia Diagnosis (Q35750755) (← links)
- Cerebrospinal fluid Aβ42 levels and APP processing pathway genes in Parkinson's disease (Q35772659) (← links)
- BACE2 Expression Increases in Human Neurodegenerative Disease (Q35917682) (← links)
- Development of a specific ELISA to measure BACE1 levels in human tissues (Q38630403) (← links)
- Will posttranslational modifications of brain proteins provide novel serological markers for dementias? (Q36072517) (← links)
- Fluid biomarkers in Alzheimer disease (Q36186513) (← links)
- Upcoming candidate cerebrospinal fluid biomarkers of Alzheimer's disease (Q36337525) (← links)
- Neurochemical biomarkers in Alzheimer's disease and related disorders. (Q36366891) (← links)
- Soluble amyloid precursor protein 770 is released from inflamed endothelial cells and activated platelets: a novel biomarker for acute coronary syndrome (Q36418965) (← links)
- Distinct patterns of APP processing in the CNS in autosomal-dominant and sporadic Alzheimer disease (Q36756941) (← links)
- Fluid biomarkers in Alzheimer's disease - current concepts (Q36953503) (← links)
- The Cerebrospinal Fluid Neurogranin/BACE1 Ratio is a Potential Correlate of Cognitive Decline in Alzheimer's Disease (Q37169136) (← links)
- Potential fluid biomarkers for pathological brain changes in Alzheimer's disease: Implication for the screening of cognitive frailty (Q37297626) (← links)
- Association of cerebrospinal fluid Aβ42 with A2M gene in cognitively normal subjects (Q37383709) (← links)
- Update on amyloid-beta homeostasis markers for sporadic Alzheimer's disease (Q37387103) (← links)
- CSF Presenilin-1 complexes are increased in Alzheimer's disease (Q37485864) (← links)
- The effects of different familial Alzheimer's disease mutations on APP processing in vivo (Q37645358) (← links)
- BACE1 Dynamics Upon Inhibition with a BACE Inhibitor and Correlation to Downstream Alzheimer's Disease Markers in Elderly Healthy Participants (Q37664735) (← links)
- Biomarkers for Alzheimer's disease: academic, industry and regulatory perspectives (Q37769104) (← links)
- Amyloid β (Aβ) and phospho-tau (p-tau) as diagnostic biomarkers in Alzheimer's disease (Q37845821) (← links)
- Cerebrospinal fluid biomarkers for Alzheimer's disease: the present and the future. (Q37895052) (← links)
- Role of CSF biomarkers in the diagnosis of prodromal Alzheimer's disease (Q37921309) (← links)
- Regulation of α-secretase ADAM10 expression and activity (Q37942089) (← links)
- What makes a prognostic biomarker in CNS diseases: strategies for targeted biomarker discovery? Part 2: chronic progressive and relapsing disease. (Q38088747) (← links)